1AI 12.5% 0.9¢ algorae pharmaceuticals limited

My connection, page-21

  1. 16,698 Posts.
    lightbulb Created with Sketch. 2380
    The reason for doing the next trial on a commercial basis is so that it will be more or less self-funding. Otherwise it would be extremely expensive to treat and follow 100 patients for a year, and the we don't know what demands the FDA might make for trial.
 
watchlist Created with Sketch. Add 1AI (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.001(12.5%)
Mkt cap ! $15.18M
Open High Low Value Volume
0.8¢ 1.0¢ 0.8¢ $4.299K 477.8K

Buyers (Bids)

No. Vol. Price($)
2 329609 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 978773 4
View Market Depth
Last trade - 15.59pm 26/07/2024 (20 minute delay) ?
1AI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.